Psychiatr. praxi. 2011;12(3):98-99

Antidepressants augmentation with antipsychotics

MUDr.Bc.Libor Ustohal, Ph.D., prof.MUDr.Eva Češková, CSc., doc.MUDr.Radovan Přikryl, Ph.D.
CEITEC-MU, Psychiatrická klinika LF MU a FN Brno

Treatment of resistant depression is particularly complicated. Just these patients need often hospitalization, what means burden on

them and on the public health system. Second generation antipsychotics perform nowadays more important role in the treatment of

treatment resistant depression and among them especially quetiapine, which was recently approved as the first antipsychotic in this

indication in our country. Aripiprazole is another antipsychotic agent convenient for depressive patients. A case study showing the use

of quetiapine XR and aripiprazole in the antidepressants augmentation is presented in this article.

Keywords: treatment resistant depression, quetiapine, aripiprazole, augmentation

Published: July 20, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ustohal L, Češková E, Přikryl R. Antidepressants augmentation with antipsychotics. Psychiatr. praxi. 2011;12(3):98-99.
Download citation

References

  1. Baldwin DS, Hirschfeld RMA. Depression. Second edition. Oxford: Health Press 2005: 82.
  2. Keller MB. Issues in Treatment-Resistant Depression. J Clin Psychiatry 2005; 66 (Suppl 8): 5-12.
  3. Thase M. New Approaches to Managing Difficult-to-Treat Depressions. J Clin Psychiatry 2003; 64 (Suppl 1): 3-4.
  4. Švestka J. Nová psychofarmaka: antipsychotikum quetiapin. Psychiatrie 2000; 2: 120-133.
  5. Nelson JC. Adjunctive Atypical Antipsychotics in Medication-Resistant Depression. CNS Spectr 2010; 15: 6 (Suppl 7): 10-13. Go to original source... Go to PubMed...
  6. Švestka J, Höschl C, Anders M, et al. Možnosti použití aripiprazolu v léčbě bipolární afektivní poruchy. Konsensus expertů v České republice. Psychiatrie 2010; 4: 218-224.
  7. Berman RM, Marcus RN, Swanink R, et al. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2007; 68 (6): 843-853. Go to original source... Go to PubMed...
  8. Seifertová D, Bareš M, Kopeček M. Antipsychotika v léčbě farmakorezistentní deprese. Psychiatr praxi 2006; 3: 122-125.
  9. Bareš M, Novák T. Depresivní porucha. In: Seifertová D, Praško J, Horáček J, Höschl C (eds.). Postupy v léčbě psychických poruch. Academia Medica Pragensis 2008: 103-130.
  10. Anders M, Raboch J, Kryl M. Depresivní porucha. In: Raboch J, Anders M, Hellerová P, Uhlíková P (eds.). Psychiatrie: Doporučené postupy psychiatrické péče III. Tribun EU 2010: 141-155.




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.